Company intelligence / Profile preview

KSL Pharmaceuticals

Williamsville, New York, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

KSL Biomedical is a translational medicine company focused on the development and commercialization of innovative diagnostic and therapeutic products. The company operates a vertically integrated model that includes research and development, clinical laboratory services, and intellectual property licensing. Their portfolio spans oncology, immunology, and infectious diseases, with a significant emphasis on precision medicine and companion diagnostics. KSL Biomedical aims to bridge the gap between laboratory discovery and clinical application to improve patient outcomes globally.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Small moleculeDiagnostic assayMonoclonal antibody
Industry: Biotech

Partnerships

University at BuffaloRoswell Park Comprehensive Cancer Center

Beyond the preview

Go deeper on KSL Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KSL Pharmaceuticals.

Explore the full profile